Yamamoto, K., Nakayama, I., & Shitara, K. Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyond. SAGE Publishing.
Chicago Style (17th ed.) CitationYamamoto, Kazumasa, Izuma Nakayama, and Kohei Shitara. Emerging Evidence of Targeting Non-oncogenic Drivers for Gastric Cancer: Claudin18.2 and Beyond. SAGE Publishing.
MLA (9th ed.) CitationYamamoto, Kazumasa, et al. Emerging Evidence of Targeting Non-oncogenic Drivers for Gastric Cancer: Claudin18.2 and Beyond. SAGE Publishing.
Warning: These citations may not always be 100% accurate.